Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H24N4O2 |
| Molecular Weight | 388.4623 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2C=CC3=C(N=C4C(C=CC=C4C(=O)N[C@H](C)CN(C)C)=N3)C2=CC=C1
InChI
InChIKey=ACAXGYADTLFREX-CQSZACIVSA-N
InChI=1S/C23H24N4O2/c1-14(13-27(2)3)24-23(28)17-8-5-9-18-22(17)26-21-16-7-6-10-20(29-4)15(16)11-12-19(21)25-18/h5-12,14H,13H2,1-4H3,(H,24,28)/t14-/m1/s1
| Molecular Formula | C23H24N4O2 |
| Molecular Weight | 388.4623 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 16:33:56 GMT 2025
by
admin
on
Tue Apr 01 16:33:56 GMT 2025
|
| Record UNII |
Q2L4XU3YX6
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Code | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9886593
Created by
admin on Tue Apr 01 16:33:56 GMT 2025 , Edited by admin on Tue Apr 01 16:33:56 GMT 2025
|
PRIMARY | |||
|
346689-77-8
Created by
admin on Tue Apr 01 16:33:56 GMT 2025 , Edited by admin on Tue Apr 01 16:33:56 GMT 2025
|
PRIMARY | |||
|
Q2L4XU3YX6
Created by
admin on Tue Apr 01 16:33:56 GMT 2025 , Edited by admin on Tue Apr 01 16:33:56 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Mechanism of Action: DNA topoisomerase I inhibitors, Type II DNA topoisomerase inhibitors; Highest Development Phase: Discontinued for Cancer
|
||
|
ACTIVE MOIETY |
XR11576, a novel phenazine, was developed as an inhibitor of both topoisomerase I and II. XR11576 demonstrated potent cytotoxic activity against a variety of human and murine tumor cell lines (IC50=6-47 nM). Its activity profile was comparable to or better than that of many widely used anticancer drugs.
|
